BIOA
BioAge Labs, Inc
7.90$
-6.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +66.2% | -14.8% | +49.9% | -9.9% | -11.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -8.7% | – | – | |
| – | – | – | – | – | – | – | +66.2% | -14.8% | +49.9% | -12.0% | -9.5% | – | |
| – | +54.3% | -7.5% | +12.3% | +91.2% | -4.0% | -42.2% | +78.6% | -6.7% | +32.3% | -16.7% | +19.4% | – | |
| – | +4.7% | -0.6% | +37.4% | -1.4% | +29.7% | +10.6% | +8.1% | -9.0% | +4.8% | +10.5% | -4.1% | – | |
| – | +37.5% | -5.8% | +19.2% | +62.1% | +2.5% | -29.4% | +51.9% | -7.3% | +25.0% | -10.8% | +13.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.5% | -52.4% | -63.6% | -12.4% | -17.8% | -20.1% | -21.2% | -25.9% | -38.3% | -57.6% | -97.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -63.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.